Your Article Summary
See Latest ArticlesPatterns of managing chronic hepatitis B treatment-related drug resistance: a survey of physicians in Mainland China, South Korea, Taiwan, and Thailand
Hepatology International, 06/26/09
Chainuvati S et al. - Limited access to HBV resistance tests causes physicians in Asia to manage suspected resistance by various HBV DNA assays and ALT tests. This raises concerns that resistance may not be detected early enough to be rescued efficiently.
Related Articles
Entecavir for the long-term treatment of chronic hepatitis B
Expert Review of Anti-infective Therapy, 11/09/09
Relevance Score: 83%
Hepatitis B Virus Resistance to Nucleostide Analogues
Gastroenterology, 10/28/09
Relevance Score: 82%
Impact of Routine Hepatitis B Immunization on the Prevalence of Chronic Hepatitis B Virus Infection in the Marshall Islands and the Federated States of Micronesia
The Pediatric Infectious Disease Journal, 10/27/09
Relevance Score: 82%
Therapeutic vaccination and novel strategies to treat chronic HBV infection
Expert Review of Gastroenterology & Hepatology, 10/16/09
Relevance Score: 82%
Age-specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B
Hepatology, 11/18/09
Relevance Score: 81%
Today in Hepatitis...keeping you current
Receive free subspecialty "5-minute updates" via email
Optimizing the treatment of chronic viral hepatitis C
Expert Review of Gastroenterology & Hepatology, 11/30/09
Hepatitis C virus/human immunodeficiency virus coinfection in hemophiliacs: high rates of sustained virologic response to pegylated interferon and ribavirin therapy
Journal of Thrombosis and Haemostasis, 11/30/09
Plasma HCV-RNA decline in the first 48 h identifies hepatitis C virus mono-infected but not HCV/HIV-coinfected patients with an undetectable HCV viral load at week 4 of peginterferon-alfa-2a/ribavirin therapy
Journal of Viral Hepatitis, 11/30/09